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SYNOPSIS

The thesis entitled “The approach for the total synthesis of (+) - Migrastatin and total synthesis of Ophiocerins B& C” is divided into three chapters.
CHAPTER I: Introduction and earlier synthetic approaches of (+) - Migrastatin and a small review on desymmetrization.
CHAPTER II: The stereoselective synthesis of C7-C15 key fragment of (+) - Migrastatin.
CHAPTER III: This chapter is divided into two sections. 
	Section A: Introduction of pyran containing bioactive natural products.
	Section B: The first total synthesis of Ophiocerins B&C.




This chapter describes the introduction to tumour angiogenesis which leads to cancer and natural products having anti angiogenesis activity. It also describes the previous synthetic approaches of migrastatins, with proven anti metastasis activity. Also a brief literature survey on “desymmetrization technique” a strategy used for introducing chirality into the target (+) Migrastatin is given.  

	

This chapter explains the stereoselective synthesis of C7-C15 fragment of (+)-Migrastatin.

Migrastatin 1 (Figure 1) is a novel macrolide natural product, isolated from a cultured broth of Streptomyces sp. MK929-43F1 by Imoto and co-workers in 2000. Recently, it was shown by Kosan Bioscience researchers that cultures of Streptomyces platensis (strain NRRL 18993) also produce migrastatin. Migrastatin displays a remarkable inhibitory effect on the migration of human tumor cells. The suppression of tumor cell migration is of great interest, potentially as a model for a therapeutic approach to the treatment of tumor metastasis. Furthermore, migrastatin selectively inhibits the anchorage-independent growth of human small cell lung carcinoma Ms-1 cells.  In 2002, the relative and absolute configuration of migrastatin was determined by X-ray crystal structure analysis of a derivative of 1. 

These potent anticancer properties render migrastatin an interesting target for total synthesis (Figure 1).




	



Migrastatin (1)
Figure 1

Some of the synthetic approaches for the synthesis of (+) Migrastatin(1) have been disclosed in literature. Our general synthetic strategy towards the total synthesis of (+) Migrastatin envisaged the preparation of key fragment C7-C15 via C2 desymmetrization technique of lactone which is generated from bicyclic ketone. For the construction of the macrocycle, we envisioned ester bond formation, followed by ring-closing metathesis (RCM) to set up the C6-C7 double bond. Accordingly, the retrosynthetic analysis was designed (Scheme 1).


RETROSYNTHESIS:


















Synthesis of lactone intermediate (4)
The synthesis of lactone intermediate 4 was achieved from bicyclic ketone 5, which was inturn synthesized from furan and 2, 4-dibromo-3-pentanone. Accordingly, the acid catalyzed dibromination of 3-pentanone 6 afforded the dibromo compound 7.  The dibromo compound 7 when treated with furan in the presence of Zn-Cu couple underwent a [3+4] cycloaddition reaction to afford the compounds 5, 8 and 9 in the ratio 8:1:1. These bicyclic ketones on selective reduction with DIBAL-H gave the corresponding alcohols (Scheme 2).

The required alcohol 10 was isolated from the other isomers using column chromatography and the structure was confirmed from spectral studies. The hydroxyl group of compound 10 was protected as its benzylether 11 using NaH and benzylbromide 










in 90% yield. Asymmetric hydroboration of olefin 11 using (–)-diisopinocampheylborane (Ipc2BH) proceeded smoothly gave the alcohol 12 (95% yield) with high enantiomeric purity.  The alcohol 12 was converted to the lactone 14 by a two step sequence; PCC oxidation of alcohol 12 followed by Baeyer-Villiger oxidation afforded the lactone 14 in 90% yield. The lactone 14 was subjected to regioslective methylation using LDA and methyl iodide to afford the methylated lactone 4 in 92% yield (Scheme 3). Thus the lactone compound 4 was employed as a common precursor for key fragment. 











Synthesis of C7-C15 fragment:
	The lactone intermediate 4 contains six stereoselectively functionalized carbons to serve as the C9 to C15 carbons of the (+)-Migrastatin and further functionalizations were carried out on the compound 4 to give corresponding fragment 3. Accordingly, hydrolysis of the bicyclic lactone 4 with catalytic amount of sulphuric acid in methanol afforded acetal 15 along with a minor amount of the -isomer (at C-1 center). The compound 15 was treated with LiAlH4 in dry THF to give the alcohol 16. (Scheme 4)






Cleavage of secondary benzyl protecting group of compound 16 was achieved using Li-naphthalenide, which afforded the diol 17 in 90% yield. In order to achieve the selective protection of primary hydroxy group in diol 17 as its t-butyl diphenylsilylether, the diol was treated with 1.1 equivalent of t-butyldiphenyl chlorosilane and imidazole in dichloromethane at 25 °C to afford mono protected silyl ether 18 in 98% yield. 
(Scheme 5)












The secondary alcohol 18 was mesylated using 2.5 equivalent of mesyl chloride in presence of triethylamine in dry CH2Cl2 at 25 °C to afford 19 in 90% yield. 










The mesyl compound 19 was treated with DBU (neat) and heated at 70oC for 8-12h, which gave the mixture of olefin compounds 3 & 20 in 80% overall yield. 
(Scheme 6)
The acid hydrolysis of anomeric methoxy group in compound 3 using IR-120 acid resin, Dowex, H2SO4/dioxan etc. did not work out according to the expectations. After several experimentation it was found that hydrolysis using AcOH: H2O: THF (6:3:1) at 50-55 °C afforded the expected product lactol 21 in 60% yield. The lactol was oxidized using bis(acetoxy)iodobenzene (BAIB) and 2,2,6,6-tetramethylpiperidine-N-oxide (TEMPO), in dichloromethane at ambient temperature to yields the lactone 22 in 98%. (Scheme 7)











For correlating the stereochemistry at C-10, epimerization of methyl group was performed. 











The lactone 22 was treated with DBU in dry THF at -10 oC to afford the required epimer 23 in 45% yield after isolation and purification with column chromatography. When the reaction temperature is increased to rt or maintained for prolonged reaction times, complete isomerization of double bond occurs to yield 24. (Scheme 8)

The epimerized lactone 23 was reduced with DIBAL-H in anhydrous THF at -78 oC resulted in lactol 25. Exposure of  crude lactol 25 to ethoxycarbonylmethylene triphenylphosphorane in toluene at reflux conditions resulted in ring opening of pyran to α,β-unsaturated ester with secondary alcohol 26 in 90% overall yield for the two steps. (Scheme 9) 










The secondary alcohol 26 was silylated using TESCl, imidazole in dichloromethane to provide the fully protected α, β-unsaturated ester 27 in 94% yield. 














The α,.β-unsaturated ester 27 was exposed to the Sharpless asymmetric dihydroxylation using AD mix-α,MeSO2NH2 in t-BuOH/H2O (1:1) to give diol 28 (72% yield). Regioselective dihydroxylation occurred on α, β-unsaturated ester when compared to the isolated tri substituted olefin. This might have arisen due to the steric hindrance prevailing on isolated olefin. (Scheme 10) 

 In compound 28, α- diol adjacent to carboxylate ester was selectively protected as methyl ether by using Gurjar’s protocol with slight modification. The diol was treated with silver oxide, methyl iodide and MS 4Ao in acetonitrile at rt to afford mono protected methyl ether 29 selectively in 80% yield. 

The secondary hydroxyl group of compound 29 was protected as its tert-butyl dimethyl silylether using 2, 6-lutidine and tert-butyl dimethyl silyl trifluoromethane sulfonate in dichloromethane at -23 to 0 °C to afford the compound 30 in 90% yield. (Scheme 11)















Reduction of the ester functionality in 30 with DIBAL-H at -78 oC gave a mixture of products as aldehyde 31 (50%), alcohol 32 and starting material. PMR spectrum showed aldehyde resonance at δ 9.85 as singlet. To standardize the yields DIBAL-H reaction was performed at -15 o​C to room temperature to give primary alcohol. This gave 1, 3 diol 33 in (90%) with the loss of TBDMS ether linkage. (Scheme 12)











With all the stereogenic centres established and chemistry for aldehye preparation known the stage was set for terminal one carbon Wittig olefination using triphenylphosphoniummethyliodide. Initially this reaction was carried on model molecule to standardize the reaction conditions.  

The camphorsulphonic acid catalyzed ketalization of 1, 2-diol of 28 using 2,2-DMP, CSA in CH2Cl2 was rather routine to furnish 34 in 96% yield.  Reduction of the ester functionality in 34 was achieved with DIBAL-H to give the alcohol 35 in 98% yield. The alcohol was oxidized to the aldehyde, which was subsequently subjected to Wittig olefination using triphenylphosphoniummethyliodide in the presence of n-BuLi in THF gave the terminal olefin 36 (90% Yield for 2 steps). The less polar olefin is accompanied with minor impurity, hence proceeded for further reaction with out much purification. Deprotection of TES group in compound 36 functionality was achieved with AcOH: H2O: THF (3:1:1) at rt to free secondary alcohol 37 in 80%. (Scheme 13) 

















Encouraged with the results on model molecule, terminal olefination was carried on actual target in routine fashion. The aldehyde 31 was reacted with triphenylphosphonium methyliodide in the presence of n-BuLi in THF at -78 oC and allowed to stir at rt for 2h gave a streak of spots on TLC. There was slight progress in reaction when reaction temperature was lowered to -10 oC from rt but product could not be isolated as the resulting product was highly non polar. (Scheme 14)











The above result prompted us to work on 1, 3 diol 33. This diol 33, on selective oxidation in the presence of bis(acetoxy)iodobenzene (BAIB) and 2,2,6,6-tetramethylpiperidine-N-oxide (TEMPO), followed by exposure of the crude β-hydroxy aldehyde to triphenylphosphonium methyliodide in the presence of n-BuLi in THF at -78oC gave undesired product exclusively. (Scheme 15)








From the above reaction it became evident that aldehyde 31 is not stable in basic conditions. The alpha methoxy group in aldehyde 31 might be eliminated or racemized in basic conditions. Hence we adapted acidic reaction conditions i.e.Tebbe reagent protocol for methylenation of aldehyde.














The aldehyde 31 was treated with Tebbe ragent (0.51M in toluene, 1.2 equiv), dry pyridine (0.01equiv) in anhydrous THF at -78 oC and warmed to -15 oC. The reaction did not proceed according to TLC. Few experiments were conducted by changing the reaction conditions. There was no indication of the product. It was concluded that aldehyde can be recovered in acidic conditions. (Scheme 16)    

In conclusion synthesis of fully functionalized C7-C15 fragment which attributes to the core skeleton of (+)-Migrastatin has been achieved. This involved a novel strategy in which bicyclic intermediate has been elaborated in a stereo controlled manner by using desymmetrization of meso-bicyclic compound using asymmetric hydroboration. The further optimization of methylenation reaction is currently under progress to complete the total synthesis of (+)-Migrastatin 1 in our laboratory.



                                   

This chapter is divided into two sections.

Section A:  Introduction of pyran containing bioactive natural products.
Tetrahydropyran skeleton features in a variety of biologically active natural products such as polyether antibiotics, marinetoxins and pheromones. Several of the polyether antibiotics are commercially important and their value as well as their elaborate structure has stimulated the interest of organic chemists. 

Section B: The first total synthesis of Ophiocerins B &C.
Ophiocerins A–C (1–4), (Figure1) the diasteromeric tetrahydropyran derivatives were isolated from the cultures of freshwater aquatic fungi Ophioceras venezuelense (Magnaporthaceae) appear to be the first natural products described from the genus Ophioceras. The isolation, structures, absolute and relative stereochemical assignments of these moieties were determined by Shearer et al. in 2005. Antagonistic effects among competing aquatic fungi have been reported from a chemical standpoint.






	Figure 1

Biosynthetically, compounds 1–4 (Figure 1) could be envisioned to arise from either polyketide or monosaccharide precursors, as they bear resemblance to relatively rare triketide products such as triacetic acid lactone, as well as to sugar-derived molecules such as deoxyhexoses, anhydroglucitol, dihydropyrans, or kojic acid. The presence of an isocrotonyl group is also somewhat unusual, although it has been reported as a component of trichothecin and trichothecinols A–C isolated from Trichothecium oroseum, as well as in trichothecinol of plant origin, and in isocrotonylpterosin B isolated from the bracken fern Pteridium aquilinum. The isocrotonyl moiety could arise from early steps of polyketide or fatty acid biosynthesis. The substituted tetrahydropyran core is found in number of natural products and shows excellent biological activity. Owing to the challenges posed by the substitution pattern of the tetrahydropyran ring, the synthesis of these compounds has attracted considerable attention. There were some precedents wherein structurally related synthetic products are reported but the exact stereochemistry defined was not described. This prompted us to explore the possibility of synthesizing ophiocerins B and C.

PRESENT WORK
Having a general interest in the total synthesis of pyran containing bioactive compounds, an elegant synthesis of ophiocerins B and C is accomplished for the first time with 3R, 4R, 6R and 3S, 4S, 6R-configuration. Of these three stereogenic centers, the C-3/C-4 vic-diol was created by Sharpless asymmetric dihydroxylation, while the C-6 stereocenter was achieved from known chiral epoxide. The synthesis of ophiocerins B and C defined the absolute stereochemistry of these natural products.






	


Retrosynthesis
Retrosynthetic analysis of 2 and 3 revealed that both compounds could be envisioned by adopting the Sharpless asymmetric dihydroxylation for the key intermediate 7, which could easily be prepared from the known chiral epoxide 8  (Scheme 1). In the present study, the vic-diol could be generated by an asymmetric dihydroxylation, while the C-6 stereocenter would be achieved by a known chiral epoxide.














Scheme1:   Retrosynthetic analysis of ophiocerins B & C.


Synthesis of Ophiocerins B & C: 
Synthesis of the Ophiocerins B & C was initiated with the kinetic resolution of 2-(benzyloxyethyl)oxirane 15 (obtained from 3-butenol 17 in two steps as shown scheme 2) using (S,S')-(-)-N-N'-bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt (III) to afford the chiral epoxide 8 and diol 18. (Scheme 2)










In the present study, the vic-diol could be generated by an asymmetric dihydroxylation, while the C-6 stereocenter would be achieved by a known chiral epoxide. Accordingly, reduction of chiral epoxide 8 with LiAlH4 gave secondary alcohol 9, which on silylation with TBDMSCl gave TBDMS ether 10 (98%, Scheme 2). The reductive cleavage of benzyl ether with lithium napthalenide afforded primary alcohol 11 in 94% yield. (Scheme 3)
 









The alcohol 11 was subjected to Swern oxidation, followed by C-2 Wittig olefination with ethoxycarbonylmethylene triphenylphosphorane in benzene, to furnish a key intermediate 7, as trans-product in 86% yield. An asymmetric dihydroxylation of the TBDMS-ether 7, with the respective AD-mix reagents resulted in the formation of vic-diols 6a and 6b. Asymmetric dihydroxylation with AD mix-β reagent resulted in the formation of vic-diol 6a predominantly and the diastereomeric ratio of vic-diols 6a to 6b was 98:2 while the same was 30:70 with the AD mix-α reagent. However, the diols that are formed during dihydroxylation with AD-mix-α could not be separated; hence they were used as such in further transformations. Both products 6a and 6b gave the target molecules 2 and 3 in later stages. This observation was in agreement with the results reported in literature. 















The acetonation of diols 6a and 6b with 2, 2-DMP and catalytic CSA resulted in 12a and 12b in 89%. Reduction of the ester and cleavage of the TBS ether occurred simultaneously with LiAlH4 at reflux conditions resulted in 5a and 5b in 85%, respectively. (Scheme 4) 











We envisaged a concomitant cyclization after tosylation of the 5a and 5b would occur in one pot, but surprisingly, monotosylates 13a and 13b were isolated in 90% yield using p-toluenesulfonyl chloride and NaH in THF. Finally, the cyclization was attempted with various bases like NaH, K2CO3, DBU, and pyridine. None of them was found to be successful. Interestingly, the desired cyclization was achieved using KOtBu (3 equiv) in THF. Accordingly, treatment of 13a with KOtBu (3 equiv) in THF gave the cyclized products 2 (97%) after the removal of acetonide in pyran moiety 14a by using catalytic p-TSA in methanol at rt. (Scheme 5) Similarly, 13b is converted to 14b which furnished 3 (70%) and 2 (30%) in respective manner. (Scheme 6) 






















Ophiocerin B (2) is a yellow liquid with optical rotation [α]D 25 –34.0 (c 0.25, CH2Cl2) and ophiocerin C (3) is a white solid with optical rotation [α]D 25 +42.2 (c 0.1,CH2Cl2). The spectroscopic analyses and optical rotation values were in accordance with the data reported in literature.

In summary, we have described an elegant synthesis of both ophiocerins B and C in a stereoselective manner using the Sharpless dihydroxylation as a key step. This study accomplished the total synthesis of 2 and 3. Synthesis of ophiocerin A with configuration 3R, 4S, 6R can be achieved by an asymmetric dihydroxylation of a key intermediate, i.e. cis-olefin 7, with AD mix-β reagent and subsequent chemical transformations described herein is currently under way in our laboratory.
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